Premium
Marker Therapeutics Inc (MRKR)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is b... Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets. It develops MT-601, which is in Phase 1 trials for the treatment of lymphoma and pancreatic cancer; and MT-401-OTS, which is in a Phase 1 trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes. The company was formerly known as TapImmune, Inc. and changed its name to Marker Therapeutics, Inc. in October 2018. Marker Therapeutics, Inc. was founded in 1999 and is headquartered in Houston, Texas. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.12 | -8 | 1.5 | 1.5 | 1.35 | 70639 | 1.40795312 | CS |
| 4 | -0.07 | -4.8275862069 | 1.45 | 1.59 | 1.35 | 65483 | 1.44414496 | CS |
| 12 | 0.07 | 5.34351145038 | 1.31 | 1.79 | 1.17 | 100771 | 1.49354966 | CS |
| 26 | -0.07 | -4.8275862069 | 1.45 | 2.46 | 1.17 | 213805 | 1.68449763 | CS |
| 52 | -0.49 | -26.2032085561 | 1.87 | 4.07 | 0.8099 | 672577 | 1.48217249 | CS |
| 156 | -1.23 | -47.1264367816 | 2.61 | 9.6799 | 0.8099 | 277221 | 1.88444618 | CS |
| 260 | -1.97 | -58.8059701493 | 3.35 | 9.6799 | 0.22 | 441003 | 1.34770595 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
